{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:08:44Z","timestamp":1772755724532,"version":"3.50.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/rhu.0b013e318205092d","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T17:58:07Z","timestamp":1355767087000},"page":"23-27","source":"Crossref","is-referenced-by-count":118,"title":["Rapid and Sustained Remission of Systemic Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome Through Treatment With Anakinra and Corticosteroids"],"prefix":"10.1097","volume":"17","author":[{"given":"Normi","family":"Bruck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meinolf","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kabus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Heubner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Gahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Pessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210207","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders.","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child"},{"key":"R2-5-20210207","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"R4-5-20210207","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","article-title":"Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases.","volume":"129","author":"Mouy","year":"1996","journal-title":"J Pediatr"},{"key":"R5-5-20210207","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R6-5-20210207","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pbc.21019","article-title":"Etanercept for therapy-resistant macrophage activation syndrome.","volume":"50","author":"Makay","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R7-5-20210207","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/ncprheum0919","article-title":"A case of macrophage activation syndrome successfully treated with anakinra.","volume":"4","author":"Kelly","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R8-5-20210207","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3899\/jrheum.091046","article-title":"Macrophage activation syndrome treated with anakinra.","volume":"37","author":"Durand","year":"2010","journal-title":"J Rheum"},{"key":"R9-5-20210207","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.1780290216","article-title":"A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis.","volume":"29","author":"Cassidy","year":"1986","journal-title":"Arthritis Rheum"},{"key":"R10-5-20210207","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr"},{"key":"R11-5-20210207","first-page":"2081","article-title":"Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis.","volume":"33","author":"Behrens","year":"2006","journal-title":"J Rheumatol"},{"key":"R12-5-20210207","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1096-911X(199607)27:1<21::AID-MPO5>3.0.CO;2-W","article-title":"Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis.","volume":"27","author":"Henter","year":"1996","journal-title":"Med Pediatr Oncol"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e318205092d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:55:21Z","timestamp":1620971721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201101000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e318205092d","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}